MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Characterization of sleep disturbances in a prospective population-based cohort to investigate Parkinson’s disease

    S. Tunc, J. Hampf, E.J. Vollstedt, K. Hückelheim, E. Warrlich, C. Kritzinger, C. Bibergeil, J. Graf, C. Klein, M. Kasten (Lübeck, Germany)

    Objective: To study sleep disturbances in Parkinson's disease (PD) in a prospective population-based cohort. Background: Sleep disturbances such as daytime sleepiness are frequent in PD.…
  • 2016 International Congress

    Longitudinal evolution of excessive daytime sleepiness in early Parkinson’s disease

    T. Simuni, C. Caspell-Garcia, J. Long, C.S. Coffey, W. Oertel, S. Lasch, K. Marek, On behalf of the PPMI Sleep Working Group (Chicago, IL, USA)

    Objective: To examine longitudinal change in excessive daytime sleepiness (EDS) in the cohort of at baseline de novo Parkinson's disease (PD) subjects. Background: We have…
  • 2016 International Congress

    Patient-centered educational intervention using hand-held electronic devices

    N. Hellmers, A. Hanineva, J.C. Stribling, J. Carter, C. Henchliffe (New York, NY, USA)

    Objective: To examine feasibility, usability and initial efficacy of an e-learning intervention, using an interactive tablet-based slideshow with audio/video and quizzes. Background: Mobile tablet and…
  • 2016 International Congress

    Development and external validation of a prognostic model of mortality in Parkinson’s disease

    A.D. Macleod, I. Dalen, O.B. Tysnes, J.P. Larsen, C.E. Counsell (Aberdeen, United Kingdom)

    Objective: To develop and validate a prognostic model to predict mortality in Parkinson's disease (PD). Background: Most previous prognostic studies in PD have used unrepresentative…
  • 2016 International Congress

    Evaluation of the [ 99mTc] – TRODAT- 1 SPECT in the diagnosis of Parkinson’s disease and other movement disorders

    G. Fabiani, R. Martins Filho, H.A.G. Teive (Campina Grande do Sul, Brazil)

    Objective: Evaluation of the [ 99mTc] - TRODAT- 1 SPECT in the diagnosis of PD and other MD. Create a DATA bank for our population.…
  • 2016 International Congress

    Patients’ employment status and quality of life affect caregivers burden in Parkinson’s disease in Singapore

    K.M. Prakash, N.V. Nadkarni, W.K. Lye, E.C. Lim, E.K. Tan (Singapore, Singapore)

    Objective: This study was aimed at assessing caregiver burden (CB) and analyzing its relationship with patient's sociodemographic, motor and non-motor severity as well as health-related…
  • 2016 International Congress

    How long is the wait to see a Parkinson’s disease specialist in the United States?

    S.G. Reich, K. Holmes, J. Martello, K. Maki (Baltimore, MD, USA)

    Objective: To investigate the wait time to see a PD specialist in the US. Background: PD patients who see a specialist have better outcomes and…
  • 2016 International Congress

    Testing feasibility and utility of remote data capture technology to assess Parkinson’s disease

    J. Carter, N. Hellmers, A. Hanineva, C. Henchcliffe (New York, NY, USA)

    Objective: To test feasibility and utility of home-based video-recording uploaded from a mobile device app to a cloud-based storage platform, in order to quantitate motor…
  • 2016 International Congress

    Transcriptional profile of blood leukocyte in Parkinson’s disease patients after multi-modal exercise and tai chi training

    L. Jin, Y. Hu, T. Zhang, K. Zhang, Z. Nie, F. Chen, Q. Cai, S. Li (Shanghai, People's Republic of China)

    Objective: With next-generation sequencing, we want to get a comprehensive characterization of circulating leukocyte in patients with PD, to interrogate the shared molecular processes perturbed…
  • 2016 International Congress

    Familial Parkinson’s disease in the Province of Quebec

    L.L. Farrell, E. Pourcher, E. Nosova, M. McKenzie, I. Guella, D.M. Evans, C. Déry, M.J. Farrer (Vancouver, BC, Canada)

    Objective: We describe clinical, genealogic and genetic studies in several families with multi-incident Parkinson's disease (PD). Background: PD is a multifactorial trait for which components…
  • « Previous Page
  • 1
  • …
  • 378
  • 379
  • 380
  • 381
  • 382
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley